| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/20/2004 | US20040096392 Antibodies against cancer antigen TMEFF2 and uses thereof |
| 05/20/2004 | US20040094449 Melatonin daily dosage units |
| 05/20/2004 | US20040094145 Consist wholly or partly of linear polysaccharides, in particular 1,4- alpha -D-polyglucan |
| 05/20/2004 | CA2448809A1 Pressure-sensitive adhesive sheet for medical use and process for producing the same |
| 05/19/2004 | EP1420025A1 Powder comprising water-containing beta-maltose crystals and production process and use thereof |
| 05/19/2004 | EP1420010A1 Amphoteric lipid compound and use thereof |
| 05/19/2004 | EP1419803A2 Pharmaceutical composition for topical administration comprising an antiviral substance and a glucocorticoid |
| 05/19/2004 | EP1419790A1 A solution comprising an olefinic diol and a pharmaceutically active compound |
| 05/19/2004 | EP1419789A2 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend, and contrast agents based on these |
| 05/19/2004 | EP1419786A1 Method for the selective and quantitative functionalization of immunoglobulin fab fragments, conjugate compounds obtained with the same and compositions thereof |
| 05/19/2004 | EP1419782A1 Use of consensus interferon for reducing the side-effects of interferon treatment in viral hepatitis |
| 05/19/2004 | EP1419777A1 Use of glycyrrhizin and its derivatives as MCP-1 production inhibitors |
| 05/19/2004 | EP1419774A1 Pharmaceutical formulations and methods comprising intranasal morphine |
| 05/19/2004 | EP1419766A1 Controlled-release formulations coated with aqueous dispersions of ethylcellulose |
| 05/19/2004 | EP1419761A1 Cosmetic composition comprising a complex of cyclodextrin and vitamin F |
| 05/19/2004 | EP1419393A1 Tumor specific oligosaccharide sequences and use thereof |
| 05/19/2004 | EP1419256A2 Conjugates for the modulation of immune responses |
| 05/19/2004 | EP1419191A1 Process for the preparation of activated polyethylene glycols |
| 05/19/2004 | EP1419172A2 Bi-directional synthesis of oligoguanidine transport agents |
| 05/19/2004 | EP1419005A1 Stable coated microcapsules |
| 05/19/2004 | EP1418951A1 Transdermal therapeutic system (tts) with fentanyl as active ingredient |
| 05/19/2004 | EP1418947A1 Pharmaceutical compositions comprising polysaccharide conjugates for inhibiting the metastasis or preventing the recurrence of malignant tumor |
| 05/19/2004 | EP1418945A2 Micellar drug delivery vehicles and uses thereof |
| 05/19/2004 | EP1418942A2 Poxvirus-containing compositions and process for their preparation |
| 05/19/2004 | EP1418925A2 Bioabsorbable adhesive compunds and compositions |
| 05/19/2004 | EP1418918A2 Compositions and methods for targeting cerebral circulation and treatment of headache |
| 05/19/2004 | EP1418905A1 Therapeutic agent for depletion of an unwanted protein population from plasma |
| 05/19/2004 | EP1418903A2 Prostanoids augment ocular drug penetration |
| 05/19/2004 | EP1418895A1 Transdermal therapeutic system based on polyacrylate-contact-bonding adhesives without functional groups |
| 05/19/2004 | EP1418894A2 Transdermal therapeutic system with fentanyl or related substances |
| 05/19/2004 | EP1418893A1 Compositions and techniques for localized therapy of restenosis |
| 05/19/2004 | EP1418892A1 Synergistic mixed poloxamer systems for the solubilisation of drugs |
| 05/19/2004 | EP1418891A1 Anaesthetic formulations of propofol |
| 05/19/2004 | EP1418889A2 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 05/19/2004 | EP1418881A2 Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide |
| 05/19/2004 | EP1418869A1 Kavalactone compositions and methods of use |
| 05/19/2004 | EP1418862A2 Individualized addiction cessation therapy |
| 05/19/2004 | EP1418860A2 Oral care substance delivery strip |
| 05/19/2004 | EP1299287A4 Methods of producing a terminally sterilized topical patch preparation |
| 05/19/2004 | EP1292539B1 Micronised barium sulphate |
| 05/19/2004 | EP1265618A4 Anaesthetic composition |
| 05/19/2004 | EP1235555B1 Stable galenic preparations comprising a benzimidazol and method for the production thereof |
| 05/19/2004 | EP1220849B1 Bicyclic compounds composition and method for stabilizing the same |
| 05/19/2004 | EP1200100A4 Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regeneration |
| 05/19/2004 | EP1137373A4 Biocompatible crosslinked polymers |
| 05/19/2004 | EP1096922A4 Improved stable topical ascorbic acid compositions |
| 05/19/2004 | EP1041978A4 Methods of inactivating bacteria including bacterial spores |
| 05/19/2004 | EP1037927B1 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 05/19/2004 | EP1011734B1 Gene therapy vehicle comprising dermal sheath tissue |
| 05/19/2004 | EP0966273B1 Transdermal or topical plaster system with a polyacrylate matrix with improved physical properties |
| 05/19/2004 | EP0608433B1 Composition for dermatologic preparation |
| 05/19/2004 | DE60100389T2 Fettlösliche Substanzen enthaltende Granulate und Verfahren zu ihrer Herstellung Fat-soluble substances containing granules, and processes for their preparation |
| 05/19/2004 | CN1498115A Hydroxyalkyl starch-active agent-conjugate |
| 05/19/2004 | CN1498114A Pharmaceutical composition having reduced tendency for drug crystallization |
| 05/19/2004 | CN1498113A Insulin preparations, which donot contain any zinc or only small quantity of zinc of improved stability |
| 05/19/2004 | CN1498106A Pharmaceutical forms of epothilones for oral administration |
| 05/19/2004 | CN1498096A Condom with erectogenic composition |
| 05/19/2004 | CN1496974A Chloramineone and haptene, immuongen, antibody and coupler of its metabolite |
| 05/19/2004 | CN1496743A Medicine composition of adding active component which undissolved in water in carrier composition and its preparing method |
| 05/19/2004 | CN1496742A Medicine composition of macrolides or cyclosporin and polyoxide saturated hydoxy fatty acid |
| 05/19/2004 | CN1496738A Fenofibrate medicine composition with high bio-availability and preparation method thereof |
| 05/19/2004 | CN1496736A Use of neuron sodium ion pass antagonist for controlling homothermal animal ectoparasite |
| 05/19/2004 | CN1150033C Immunopptentiating composition |
| 05/19/2004 | CN1150031C Use of histamine of therapeutic purposes |
| 05/19/2004 | CN1150030C 重组人甲胎蛋白及其用途 And its use of recombinant human alpha-fetoprotein |
| 05/19/2004 | CN1150001C Injections contg. lipid A analogues and process for preparation thereof |
| 05/19/2004 | CN1150000C Compositions containing diphosphonic acids |
| 05/19/2004 | CN1149999C Pharmaceutical composition containing vitamin D and calcium, their preparation and therapeutic use |
| 05/19/2004 | CN1149997C Medicine composition |
| 05/19/2004 | CN1149993C Pharmaceutical moxifloxacin preparation |
| 05/19/2004 | CN1149992C Antimycotic gel with active substance release |
| 05/19/2004 | CN1149984C Anesthetic compsn. for intravenous injection comprising propofol |
| 05/19/2004 | CN1149982C Controlled releasing of steroid from sugarcoating |
| 05/19/2004 | CN1149981C Product with powder stable vitamine and/or carotenoid its producing process |
| 05/19/2004 | CN1149980C Spray-dried powders with high edible-oil loading based on non-bydrolyzed gelation and method of making such spry-dried tablettable powders |
| 05/19/2004 | CN1149978C Quinolone-containing liposome composition and their preparation method |
| 05/19/2004 | CN1149975C Compositions containing a peptide and polylactic-glycolic acid subitable for preparing subcutaneous implants with and extended release period |
| 05/19/2004 | CN1149967C Site-specitic preparation of polyethylene glycol-GRF conjujates |
| 05/18/2004 | US6738663 Implantable device and method for the electrical treatment of cancer |
| 05/18/2004 | US6737505 Water-soluble and non-peptidic polymer with a backbone covalently bonded to an alkanoic acid; drug delivery |
| 05/18/2004 | US6737427 Administering to the patient suffering with the disease caused by overproduction of mucin such as chronic obstructive pulmonary diseases including asthma, emphysema, and chronic bronchitis a mucin glycoprotein synthesis inhibitor |
| 05/18/2004 | US6737405 Mixing with polysaccharide and amino acid |
| 05/18/2004 | US6737401 Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom |
| 05/18/2004 | US6737267 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof |
| 05/18/2004 | US6737259 Modified with polyethylene glycol for treatment and inhibition of cancer and metastasis |
| 05/18/2004 | US6737234 Generating a mutant adenovirus characterized by a receptor binding affinity which is significantly weakened for card1 (catalyzed reporter deposition) relative to wild-type adenovirus |
| 05/18/2004 | US6737101 Spray-coated pharmaceutical powder compositions for transdermal administration using a needleless syringe |
| 05/18/2004 | US6737089 From the indian mulberry plant. |
| 05/18/2004 | US6737086 For accelerating and amplifying the synthesis of thermal shock proteins of cells of living beings |
| 05/18/2004 | US6737082 Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method |
| 05/18/2004 | US6737080 Laminate comprising first moisture sensitive layer including moisture sensitive component, and second moisture absorbing layer including activated desiccant; spatial separation of layers prevents components from moving between layers |
| 05/18/2004 | US6737071 Composition comprising polymers having a star structure, the polymers, and their use |
| 05/18/2004 | US6737068 Wipe formulation |
| 05/18/2004 | US6737064 Antitumor agents |
| 05/18/2004 | US6737045 Methods and compositions for the pulmonary delivery insulin |
| 05/18/2004 | US6737043 Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route |
| 05/18/2004 | US6737042 Delivery of drug esters through an inhalation route |
| 05/18/2004 | US6737005 Method of producing solid dosage forms |
| 05/18/2004 | US6736849 Surface-mineralized spinal implants |
| 05/18/2004 | CA2252310C Glucoamylase converted starch derivatives and their use as emulsifying and encapsulating agents |